Management of Genital Herpes
Appropriate management of genital herpes simplex virus (HSV) infections involves establishing the diagnosis; counselling regarding the source, natural history and risk of transmission of infection; and, in many cases, use of antiviral chemotherapy. This chapter will summarize recent advances in the laboratory diagnosis and treatment of genital herpes, including recent trials with investigational drugs. A review of the clinical presentation and natural history of genital herpes and recent progress in our understanding of the risk of sexual transmission of infection is beyond the scope of this chapter. Issues of asymptomatic shedding and risk of transmission are discussed in the chapter by Corey, this volume.
KeywordsHerpes Simplex Virus Type Genital Herpes Oral Acyclovir Recurrent Genital Herpes Intravenous Acyclovir
Unable to display preview. Download preview PDF.
- 7.Corey I., Benedetti J, Critchlow C, et al. Treatment of primary first episode genital HSV infections with acyclovir: Results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983; 12: 798x.Google Scholar
- 9.Drugs for non-HIV viral infections. The Medical Letter 1994; 36: 27–32.Google Scholar
- 11.Reichmau RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. JAMA 1984;51:2103–2107.Google Scholar
- 12.The International Valaciclovir IISV Study Group, Smiley MI., Burroughs Wellcome Co., et al. Valaciclovir and acyclovir for the treatment of recurrent genital herpes simplex virus infections. Abstract #1211, Program of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, 17–20 October, 1993.Google Scholar
- 13.Sexually transmitted disease treatment guidelines. MMWR 1993; 42 (RR-14): 1–102.Google Scholar
- 16.Sacks SI., Aoki EY, Diaz-Mitouna E, et al. Patient-Initiated Treatment (tx) of Recurrent Genital Herpes (RGII) with Oral Famciclovir (FCV): A Canadian, Multicenter, Placebo (PLB)-Controlled, Dose-Ranging Study. Abstract #H4, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4–7 October 1994.Google Scholar
- 21.Wald A, Barnum G, Selke S, et al. Acyclovir suppresses asymptomatic shedding of HSV-2 in the genital tract. Abstract #H5, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4–7 October 1994.Google Scholar
- 25.Mertz GJ, Loveless MO, Kraus SJ, et al. Famciclovir for suppression of recurrent genital herpes. Abstract #H3, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4–7 October 1994.Google Scholar
- 30.Shepp DH, Newton BA, Dandliker PS, et al. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients. Ann Intern Med 1985; 102: 783785.Google Scholar